Even before its RNA vaccine for COVID-19 made Moderna famous, the company’s founders had a vision for treating rare diseases. “When the pandemic hit, it slowed us down a little bit because we had ...
Therapies for rare autoimmune diseases are progressing with an enhanced understanding of how the immune system misfires to ...
A study in mice and human tissues linked abnormally expressed Snhg11 with reduced neurogenesis and altered plasticity, which ...
The results of research led by scientists at the University of Exeter, and at King’s College London, suggests that young people could be spared from going blind by a new genetic risk tool that could ...
In new research, the blood-brain barrier was modeled using modularized tissue derived from human cells to help give the drug discovery field a boost.
Pancreatic cancer is a complex disease with few treatment options and poor prognosis, in part due to the dearth of suitable models for studying its progression and assessing patients’ response to ...
Making the right choices in manufacturing and testing early-on is critical for gaining regulatory approval and achieving patient access faster. Charles River’s suite of cell and gene therapy solutions ...
The p53 protein variant Δ133p53α may play an important role in improving the effectiveness of chimeric antigen receptor (CAR) T cell therapy.
ROCKVILLE, MD—On a brisk, sun-splashed midweek morning in the suburbs of Washington DC, the staff at MaxCyte have double ...
The first organized stem cell culture model that resembles all three sections of the embryonic brain and spinal cord, and ...
Bristol Myers Squibb (BMS) reports that the company is investing $400 million in its Dublin 15 Cruiserath Campus (BMS ...
Scientists say they have developed a “self-driving” lab that uses artificial intelligence (AI) and automated systems to provide in-depth analyses of catalytic reactions used in chemical research and ...